These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 37674003)

  • 1. Gut commensal Kineothrix alysoides mitigates liver dysfunction by restoring lipid metabolism and gut microbial balance.
    Choi KJ; Yoon MY; Kim JE; Yoon SS
    Sci Rep; 2023 Sep; 13(1):14668. PubMed ID: 37674003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic Mixture Ameliorates a Diet-Induced MASLD/MASH Murine Model through the Regulation of Hepatic Lipid Metabolism and the Gut Microbiome.
    Zhang F; Lo EKK; Chen J; Wang K; Felicianna ; Ismaiah MJ; Leung HKM; Zhao D; Lee JC; El-Nezami H
    J Agric Food Chem; 2024 Apr; 72(15):8536-8549. PubMed ID: 38575146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes of gut microbiota in mouse models of metabolic dysfunction-associated steatohepatitis and its transition to hepatocellular carcinoma.
    Wang YL; Liu C; Yang YY; Zhang L; Guo X; Niu C; Zhang NP; Ding J; Wu J
    FASEB J; 2024 Jul; 38(13):e23766. PubMed ID: 38967214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Regulatory Effect of LPJZ-658 on Copper Deficiency Combined with Sugar-Induced MASLD in Middle-Aged Mice Based on Multi-Omics Analysis.
    Li C; Liu Z; Wei W; Chen C; Zhang L; Wang Y; Zhou B; Liu L; Li X; Zhao C
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD).
    Benedé-Ubieto R; Cubero FJ; Nevzorova YA
    Gut Microbes; 2024; 16(1):2331460. PubMed ID: 38512763
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Mak AL; Augustijn QJJ; Heymann CJF; Havik S; Verdoes X; Rios-Morales M; Bosmans LA; Verheij J; Meijnikman AS; de Jonge PA; Herrema H; de Vos WM; Nieuwdorp M; Grefhorst A; Holleboom AG
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COMPARISON OF GUT MICROBIOTA IN ALCOHOLIC AND METABOLIC-DYSFUNCION ASSOCIATED STEATOTIC LIVER DISEASE IN ANIMAL MODELS.
    Perlin CM; Longo L; Thoen RU; Uribe-Cruz C; Álvares-DA-Silva MR
    Arq Gastroenterol; 2024; 61():e23100. PubMed ID: 38511793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease.
    Martínez-Sanz J; Talavera-Rodríguez A; Díaz-Álvarez J; Rosas Cancio-Suárez M; Rodríguez JM; Alba C; Montes ML; Martín-Mateos R; Burgos-Santamaría D; Moreno S; Serrano-Villar S; Sánchez-Conde M
    Front Immunol; 2023; 14():1297378. PubMed ID: 38162648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota modulation by dietary oat beta-glucan prevents steatotic liver disease progression.
    Jaeger JW; Brandt A; Gui W; Yergaliyev T; Hernández-Arriaga A; Muthu MM; Edlund K; Elashy A; Molinaro A; Möckel D; Sarges J; Halibasic E; Trauner M; Kahles F; Rolle-Kampczyk U; Hengstler J; Schneider CV; Lammers T; Marschall HU; von Bergen M; Camarinha-Silva A; Bergheim I; Trautwein C; Schneider KM
    JHEP Rep; 2024 Mar; 6(3):100987. PubMed ID: 38328439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments.
    Pirola CJ; Landa MS; Schuman M; García SI; Salatino A; Sookoian S
    Clin Mol Hepatol; 2024 Oct; ():. PubMed ID: 39391907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAD metabolic therapy in metabolic dysfunction-associated steatotic liver disease: Possible roles of gut microbiota.
    Lu X; Yang R; Chen Y; Chen D
    iScience; 2024 Mar; 27(3):109174. PubMed ID: 38405608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lasting Effects of COVID-19 on the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
    Backer S; Khanna D
    Cureus; 2023 Sep; 15(9):e45231. PubMed ID: 37842470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Iron Diet-Induced Fatty Liver Development Is Microbiota Dependent and Exacerbated by Loss of the Mitochondrial Iron Importer Mitoferrin2.
    Klag KA; Bell R; Jia X; Seguin A; Maschek JA; Bronner M; Cox JE; Round JL; Ward DM
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
    Zazueta A; Valenzuela-Pérez L; Ortiz-López N; Pinto-León A; Torres V; Guiñez D; Aliaga N; Merino P; Sandoval A; Covarrubias N; Pérez de Arce E; Cattaneo M; Urzúa A; Roblero JP; Poniachik J; Gotteland M; Magne F; Beltrán CJ
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bariatric-induced microbiome changes alter MASLD development in association with changes in the innate immune system.
    Shera S; Katzka W; Yang JC; Chang C; Arias-Jayo N; Lagishetty V; Balioukova A; Chen Y; Dutson E; Li Z; Mayer EA; Pisegna JR; Sanmiguel C; Pawar S; Zhang D; Leitman M; Hernandez L; Jacobs JP; Dong TS
    Front Microbiol; 2024; 15():1407555. PubMed ID: 39184030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Riezu-Boj JI; Barajas M; Pérez-Sánchez T; Pajares MJ; Araña M; Milagro FI; Urtasun R
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics.
    Yuan H; Jung ES; Chae SW; Jung SJ; Daily JW; Park S
    Nutrients; 2024 Sep; 16(18):. PubMed ID: 39339660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.